Corrigendum to ‘Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)’ The American Journal of Cardiology 119 (2017) 1576–1583
Titel:
Corrigendum to ‘Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)’ The American Journal of Cardiology 119 (2017) 1576–1583
Auteur:
Baruch, Amos Mosesova, Sofia Davis, John D. Budha, Nageshwar Vilimovskij, Alexandr Kahn, Robert Peng, Kun Cowan, Kyra J. Harris, Laura Pascasio Gelzleichter, Thomas Lehrer, Josh Davis Jr, John C. Tingley, Whittemore G.